Biyun Zheng Selected Research

Therapeutic Uses

1/2021

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Biyun Zheng Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Insulin Resistance 01/2021
1	Carcinogenesis 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Fatty Liver 01/2021

Drug/Important Bio-Agent (IBA)

2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021 - 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	PowdersIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	CateninsIBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	rofecoxib (Vioxx)FDA Link 01/2021
1	ResveratrolIBA 01/2021
1	EnzymesIBA 01/2021

Therapy/Procedure

1	Therapeutics 01/2021